Comparison of the response of human FaDu squamous cell carcinoma in nude mice after hypofractionated-accelerated regimens and "curative" fractionation schedules

被引:0
|
作者
Appold, S
Baumann, M
Petersen, C
Horn, K
Eichhorn, F
机构
[1] Tech Univ Dresden, Med Fak Carl Gustav Carus, Klin & Poliklin Strahlentherapie & Radioonkol, D-01307 Dresden, Germany
[2] Univ Munster, Klin & Poliklin Strahlentherapie & Radioonkol, D-4400 Munster, Germany
关键词
fractionated irradiation; human tumor xenografts squamous cell carcinoma; TCD50; time factor; alpha/beta ratio;
D O I
10.1007/BF03038546
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Background: It has been suggested that tumors respond differently after irradiation with 10 or more fractions than with less fractionated regimens and that extrapolation from experiments with only a few fractions to "curative" regimens may be invalid. To test this hypothesis, we compared hypofractionated-accelerated treatments with "curative" fractionation schedules in human squamous cell carcinoma in nude mice. Material and Methods: FaDu tumors were transplanted subcutaneously into the hindleg of NMRI nu/nu mice. TCD50 values, i. e., the dose necessary to control 50% of the tumors locally, were determined after irradiation under ambient blood flow conditions with 5 and 10 fractions in 5 days, 10 fractions in 10 days, and 30 fractions in 15 days, 6 weeks or 10 weeks. Results: TCD50 values of the hypofractionated regimens were not significantly different and varied from 41 to 46 Gy. The number of fractions given in the same overall time had no measurable effect on local tumor control. The TCD50 after 30 fractions in 6 weeks was 30 Gy higher than after the hypofractionated regimens. This effect was caused by a substantial increase of TCD50 with overall treatment time, the dose recovered per day was 0.82 Gy (95% CI 0.66; 0.96). alpha/beta(eff) determined from all data was 58 Gy (13; infinite). Conclusions: The results of the present study compare well with our previous findings after different "curative"' fractionation schedules in the same tumor. Thus, our study does not support that tumors respond differently after application of 10 or more fractions compared to less fractionated regimens. The biological mechanisms that govern the radiation response of FaDu tumors appear to be the same for hypofractionated-accelerated and "curative' regimens. Since only one tumor was investigated, these results cannot be generalized at the present time.
引用
收藏
页码:315 / 319
页数:5
相关论文
共 50 条
  • [11] Histopathologic validation of 18F-fluorothymidine PET for detecting tumor repopulation during radiotherapy of human FaDu squamous cell carcinoma in nude mice
    Yang, Jia
    Liu, Jing
    Lee, Jason
    Cabrera, Alvin R.
    Yu, Jin-Ming
    Sun, Xin-Dong
    Bai, Guang-Hui
    Li, Yu-Hui
    Yue, Jinbo
    JOURNAL OF NUCLEAR MEDICINE, 2014, 55
  • [12] CHEMOTHERAPY OF HUMAN SQUAMOUS-CELL CARCINOMA OF CERVIX TRANSPLANTED INTO NUDE-MICE
    RANA, MW
    BENJAMIN, I
    XYNOS, FP
    SAPIENTE, R
    NALESNIK, W
    ANATOMICAL RECORD, 1979, 193 (03): : 661 - 661
  • [13] INDUCTION OF SQUAMOUS-CELL CARCINOMA IN HUMAN BRONCHI TRANSPLANTED INTO NUDE-MICE
    SHIMOSATO, Y
    KODAMA, T
    TAMAI, S
    KAMEYA, T
    GANN, 1980, 71 (03): : 402 - 407
  • [14] TREATMENT OF HUMAN SQUAMOUS-CELL CARCINOMA OF CERVIX XENOGRAFTED IN NUDE-MICE
    RANA, MW
    BENJAMIN, I
    FREEL, J
    ANATOMICAL RECORD, 1983, 205 (03): : A156 - A157
  • [15] INTRANUCLEAR FILAMENTS IN XENOGRAFTS OF HUMAN SQUAMOUS-CELL CARCINOMA IN NUDE-MICE
    BENJAMIN, I
    RANA, MW
    XYNOS, FP
    URHAHN, J
    HUMAN PATHOLOGY, 1980, 11 (01) : 87 - &
  • [16] Reproduction of diffuse invasive growth of human oral squamous cell carcinoma in nude mice
    Moriyama, M
    Kumagai, S
    Kawashiri, S
    Kojima, K
    Kakihara, K
    Yamamoto, E
    ORAL ONCOLOGY, VOL V, 1997, : 405 - 408
  • [17] CELL-CYCLE KINETICS OF A HUMAN SQUAMOUS-CELL CARCINOMA IN NUDE-MICE AND INVITRO
    MECK, RA
    YUNIS, AA
    INGRAM, M
    CELL AND TISSUE KINETICS, 1979, 12 (06): : 681 - 681
  • [18] Does heterogeneity of pimonidazole labelling correspond to the heterogeneity of radiation-response of FaDu human squamous cell carcinoma?
    Yaromina, A
    Hölscher, T
    Eicheler, W
    Rosner, A
    Krause, M
    Hessel, F
    Petersen, C
    Thames, HD
    Baumann, M
    Zips, D
    RADIOTHERAPY AND ONCOLOGY, 2005, 76 (02) : 206 - 212
  • [19] In response to "Histopathologic validation of 3′-deoxy-3′-18F-fluorothymidine PET for detecting tumour repopulation during fractionated radiotherapy in human FaDu squamous cell carcinoma in nude mice"
    Troost, Esther G. C.
    Hoeben, Bianca A. W.
    Laverman, Peter
    Bussink, Jan
    Oyen, Wim J. G.
    RADIOTHERAPY AND ONCOLOGY, 2015, 114 (03) : 417 - 418
  • [20] Toxicity and outcome in cats with oral squamous cell carcinoma after accelerated hypofractionated radiotherapy and concurrent systemic treatment
    Marconato, Laura
    Weyland, Mathias
    Tresch, Nina
    Rossi, Federica
    Leone, Vito
    Rohrer Bley, Carla
    VETERINARY AND COMPARATIVE ONCOLOGY, 2020, 18 (03) : 362 - 369